Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion.

about

Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion.

Item

http://www.wikidata.org/entity/Q47161252

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intrapleural targeted therapie ...... of malignant pleural effusion.

@en

Intrapleural targeted therapies

@nl

type

Item

label

Intrapleural targeted therapie ...... of malignant pleural effusion.

@en

Intrapleural targeted therapies

@nl

prefLabel

Intrapleural targeted therapie ...... of malignant pleural effusion.

@en

Intrapleural targeted therapies

@nl

P1476

Intrapleural targeted therapie ...... of malignant pleural effusion.

@en

P2093

Evaldo Marchi

http://www.w3.org/2001/XMLSchema#string

Juliana Puka

http://www.w3.org/2001/XMLSchema#string

Lisete Ribeiro Teixeira

http://www.w3.org/2001/XMLSchema#string

Mariana Lombardi Peres de Carvalho

http://www.w3.org/2001/XMLSchema#string

Milena Marques Pagliarelli Acencio

http://www.w3.org/2001/XMLSchema#string

Vanessa Adélia Alvarenga

http://www.w3.org/2001/XMLSchema#string

Vanessa Martins

http://www.w3.org/2001/XMLSchema#string

Vera Luiza Capelozzi

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Comprehensive molecular profiling of lung adenocarcinoma.

Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010

Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data

Molecular determinants of cetuximab efficacy.

Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Vascular endothelial growth factor: the key mediator in pleural effusion formation.

Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies.

Vascular endothelial growth factor and angiogenesis.

P304

105093-105102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21362

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285236

http://www.w3.org/2001/XMLSchema#string

P932

5739623

http://www.w3.org/2001/XMLSchema#string